Engaging 2008 Debate, Key Long Term Care Advocacy Groups Offer New Plan to Strengthen Nation's Long Term and Post-Acute Care Deliv... (ts and new LTCsavings accounts -- which ...)

HOME >> MEDICINE >> NEWS

Engaging 2008 Debate, Key Long Term Care Advocacy Groups Offer New Plan to Strengthen Nation's Long Term and Post-Acute Care Delivery System

Date:1/15/2008

ts, and new LTC savings accounts -- which individuals are incentivized to purchase in order to cover future LTC costs.

New Medicare Post-Acute Payment System Featuring Updated Patient Assessment Tools

The Centers for Medicare and Medicaid Services (CMS) will implement a new Medicare post-acute payment system based on the condition, needs and characteristics of the patient, regardless of the site where care is delivered, thus further encouraging and enhancing consumer choice. A post-acute patient assessment tool will replace the existing site-specific model and will assist in determining patient placement, care plan development, continued stay and discharge decision-making, development of quality indicators, and payment calculation. The new Medicare payment model and patient assessment will replace the current system for which each site of care has its own reimbursement system determined by varying types of patient classifications. The three long term care leaders noted and praised the fact CMS has already initiated a multi-state pilot program evaluating the care Medicare beneficiaries receive after being discharged from a hospital, and how the federal government pays for that care. Currently, they noted, Medicare pays for beneficiaries' care based on where the beneficiary receives health care services, not the nature of the care itself.

Yarwood, Rosenbloom and Kyllo also praised the work and recommendations of the recently-concluded National Commission for Quality Long Term Care (NCQLTC) headed by former U.S. Senator Bob Kerrey (D-NE) and former House Speaker Newt Gingrich (R-GA), and noted one of its key findings provides a strong rationale for the consumer education component of the plan released today.

An NCQLTC survey found 34% of Americans believe most long term care is paid for by Medicare, 20% believe most long term care is paid for by Medicaid (in fact the largest source of funding, accounting for 49% of long term care spend
'/>"/>

SOURCE American Health Care Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Young People Engaging In Sexual Activity Differ on Definitions of Virginity, Abstinence
2. Health Insurance Industry Contributions to Politicians Block Regulation, Affordability in Health Care Debate, Says FTCR
3. Treatment Advocacy Centers Top 10 Mental Illness Stories You Didnt Read in 2007
4. Leading National Patient Advocacy Group Commends Insurance Industrys Recognition, Focus on Growing National Problem of Uninsured and Underinsured Americans
5. Treatment Advocacy Center Honors Three Grassroots Mental Illness Advocates
6. Oral Health Americas Robert Klaus Honored for Outstanding Public Advocacy
7. HIV Collaborative Fund Receives Gates Foundation Grant for AIDS Treatment and Prevention Advocacy
8. BREATHE Lung Cancer Conference, Nov. 30, Offers Medical and Patient Education, Advocacy and Survivors Perspective
9. Kurt Entsminger Named Executive Director of Treatment Advocacy Center
10. Aetna HSA Online Video Wins 2007 Insight Award for Customer Advocacy in Healthcare
11. Latino Advocacy Group Investigates Immigrant Dumping by U.S. Employers

Post Your Comments:

(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... The author has released its latest ...

(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... of Autoimmune Diseases Therapeutics - Market ... Pipeline and Deals Analysis ... Summary ,, The author has ...

(Date:12/15/2009)... ALPHARETTA, Ga., Dec. 15 Hosted by ... the 4th annual event recognized 2009,s best eLearning ... all, were spread across 4 categories. The ... developed for the world,s largest hotelier, was selected ... Hours of Custom eLearning" category by the panel ...

(Date:12/15/2009)... Ill. and CHENNAI, India, Dec. 15 /PRNewswire-FirstCall/ ... ), the world leader in generic injectable ... (BSE: 524372, NSE: ORCHIDCHEM), a leading Indian ... beta-lactam antibiotics manufacturers globally, today announced an ... injectable finished-dosage form pharmaceuticals business for approximately ...

(Date:12/15/2009)... is being released by the American Health Information Management ... RHIT, CCS, FAHIMA ,, AHIMA President ... ,, On behalf of the A-H-I-M-A Board of Directors...it ... executive officer, Doctor Alan Dowling... ,, Back last summer ... who we knew could effectively replace Linda ...

[0] Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] The Venza Group Received Top Honors at the American Society of Training & Development (ASTD) eLearning Excellence Awards Ceremony Held on December 10, 2009 [0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business [0] Dowling Press Availability Tuesday, December 15, 2009 / 10:00 a.m. CST

... more than 60 orders for faster form of image-guided ... intensity-modulated radiation therapy, PALO ... ) today announced it has received more than 60 orders ... RapidArc orders have been,concentrated in North America but have also ...

... The NCCA accredited the National,Exercise & ... a five-year period, expiring March 31, 2013, ... NESTA is a professional certification organization,acting in ... education,examination, experience and ethics requirements for certification., ...

... Association urges Senators Cardin and Mikulski to quickly pass,companion ... 23 AARP thanked the,supporters and cosponsors of the ... today in the U.S. House of Representatives. The bill,prevents ... stopping,harmful cuts proposed by the administration., "Today,s vote ...

... Expert says goal is to maintain strength, not gain it, ... If you,re an athlete or fitness enthusiast who suffers a ... have to stop exercising. , , "Exercise can definitely be ... its type, the injured area should be moved and not ...

... and Tour Groups, CHICAGO, April 23 ... Bank of America Chicago Marathon has closed as ... race, marking the event,s,established capacity. A limited number ... tour groups., (Logo: http://www.newscom.com/cgi-bin/prnh/20050720/CLW086LOGO-b ), ...

... with these headaches suffer from skin discomfort, study finds, ... have migraines -- either chronic or episodic -- are ... sensitivity, new research shows. , As many as two-thirds ... condition called cutaneous allodynia. Cutaneous allodynia is skin sensitivity ...

Other Medicine News:Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 2 Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 3 Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 4 Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 5 Health News:The National Exercise & Sports Trainers Association Receives Accreditation of Its Personal Fitness Trainer Certification From the National Commission for Certifying Agencies (NCCA) 2 Health News:AARP Thanks Maryland's Representatives for Supporting Bill to Protect People in Medicaid 2 Health News:Exercise Plays Role in Recovery From Sports Injuries 2 Health News:2008 Bank of America Chicago Marathon Registration Closes as Race Reaches 45,000 Participant Capacity 2 Health News:Skin Pain, Sensitivity Rises With Migraine 2 Health News:Skin Pain, Sensitivity Rises With Migraine 3

Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability The National Exercise & Sports Trainers Association Receives Accreditation of Its Personal Fitness Trainer Certification From the National Commission for Certifying Agencies (NCCA)AARP Thanks Maryland's Representatives for Supporting Bill to Protect People in Medicaid Exercise Plays Role in Recovery From Sports Injuries 2008 Bank of America Chicago Marathon Registration Closes as Race Reaches 45,000 Participant Capacity Skin Pain, Sensitivity Rises With Migraine

(Date:12/15/2009)... -- Masimo (Nasdaq: MASI ), the inventor ... Perfusion pulse oximetry, today announced that Masimo Chairman ... 2009 Frost & Sullivan CEO of the Year ... According to Frost & Sullivan, the award is ... in understanding customer requirements, developing new technologies, delivering ...

(Date:12/15/2009)... MALVERN, Pa. and WALTHAM, Mass., Dec. 15 /PRNewswire/ ... find that methicillin-resistant Staphylococcus aureus (MRSA) ... infectious disease specialists with regard to their treatment ... activity against MRSA is among the top factors ... skin and skin structure infections. Other key factors ...

(Date:12/15/2009)... -- Bend Research Inc. announced,today that its clients may ... used in technologies developed by the firm to enhance ... Bend Research clients may now reference a ... filings with the FDA, Bend Research officials said. , ... development and know it will assist our,clients in accelerating ...

Breaking Medicine Technology:Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 2 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 3 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 4 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 5 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 6 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 2 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 3 Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient 2 An atomic level look at an HIV accomplice 61728 1 An atomic level look at an HIV accomplice 61728 2 Bioreactor for bone tissue engineering wins professor venture fair 10813 1 Bioreactor for bone tissue engineering wins professor venture fair 10813 2 Bioreactor for bone tissue engineering wins professor venture fair 10813 3 Drug studied as possible treatment for spinal injuries 10811 1 Drug studied as possible treatment for spinal injuries 10811 2 Drug studied as possible treatment for spinal injuries 10811 3

[0] Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award [0] A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections [0] Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient

... in Repeat-Dosing Study in Subjects with ALS, RICHMOND, ... ) announced today that it has opened a Phase,2 ... subjects,with ALS, a progressive, degenerative motor-neuron disease for which ... drug, SB-509, is an injectable formulation of a plasmid,encoding ...

... Sept. 3 Forest Laboratories, Inc.,(NYSE: ... announced results from,two global Phase III studies ... for the treatment of patients with chronic,obstructive ... I&II,(AClidinium CLinical Trial Assessing Efficacy and Safety ...

Other Medicine Technology:Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6

Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

Medicine Products:

Cytomegalovirus Antibody, IgG Cytology, Tzanck Smear Cytology, SurePathLiquid-Based Pap Test (AutoCyte PREP System) with Reflex to Human Papillomavirus (HPV) DNA Probe, High Risk Cytology, Pulmonary

Engaging 2008 Debate, Key Long Term Care Advocacy Groups Offer New Plan to Strengthen Nation's Long Term and Post-Acute Care Deliv...(ts and new LTCsavings accounts -- which ...),Health